Tarsus Pharmaceuticals Insider Trades
NASDAQ: TARSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 46 · $15.75M
- Shares bought / sold
- 0 / 219.21K
- Net activity
- Net selling $15.7 million
Tarsus Pharmaceuticals insider activity
Over the last 12 months, Tarsus Pharmaceuticals insiders reported 62 transactions on SEC Form 4: 0 open-market purchases and 46 sales. Insiders bought $0 and sold $15.7 million worth of stock, for net insider selling of $15.7 million. The largest seller was Azamian Bobak R., with $5.5 million in reported sales.
The most recent filing shows Azamian Bobak R. (President/CEO and Board Chair) selling 10,000 shares at $80.31 on Nov 13, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TARS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TARS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 13, 2026 | Azamian Bobak R.President/CEO and Board Chair | Sale | 10,000 | $803.10K | Form 4 |
| Sep 15, 2026 | YARNO WENDY LDirector | Option exercise | 302 | — | Form 4 |
| Sep 15, 2026 | PYOTT DAVID E IDirector | Option exercise | 201 | — | Form 4 |
| Sep 15, 2026 | LINK WILLIAM J PHDDirector | Sale | 66 | $5.28K | Form 4 |
| Sep 15, 2026 | LINK WILLIAM J PHDDirector | Sale | 759 | $59.96K | Form 4 |
| Sep 15, 2026 | LINK WILLIAM J PHDDirector | Sale | 11,675 | $914.50K | Form 4 |
| Sep 15, 2026 | LINK WILLIAM J PHDDirector | Option exercise | 201 | — | Form 4 |
| Sep 4, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 1,590 | $143.10K | Form 4 |
| Sep 4, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 1,590 | $135.15K | Form 4 |
| Sep 4, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 5,386 | $484.74K | Form 4 |
| Sep 4, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 5,387 | $457.89K | Form 4 |
| Sep 4, 2026 | Azamian Bobak R.President/CEO and Board Chair | Sale | 2,900 | $264.68K | Form 4 |
| Sep 4, 2026 | Azamian Bobak R.President/CEO and Board Chair | Sale | 7,100 | $640.92K | Form 4 |
| Sep 4, 2026 | Neervannan SeshadriChief Operating Officer | Sale | 4,564 | $387.94K | Form 4 |
| Sep 2, 2026 | Azamian Bobak R.President/CEO and Board Chair | Sale | 10,000 | $800.60K | Form 4 |
| Sep 2, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 1,590 | $127.20K | Form 4 |
| Sep 2, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 5,387 | $430.96K | Form 4 |
| Sep 1, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 4,601 | $339.83K | Form 4 |
| Jun 17, 2026 | Azamian Bobak R.President/CEO and Board Chair | Sale | 5,418 | $334.89K | Form 4 |
| Jun 17, 2026 | Azamian Bobak R.President/CEO and Board Chair | Sale | 4,582 | $280.60K | Form 4 |
| Jun 16, 2026 | Farrow Jeffrey SSee Remarks | Sale | 14,396 | $877.44K | Form 4 |
| Jun 15, 2026 | Goodrich KatherineDirector | Sale | 2,954 | $183.38K | Form 4 |
| Jun 15, 2026 | LINK WILLIAM J PHDDirector | Sale | 1,928 | $121.35K | Form 4 |
| Jun 15, 2026 | LINK WILLIAM J PHDDirector | Sale | 10,572 | $655.15K | Form 4 |
| Jun 15, 2026 | Farrow Jeffrey SSee Remarks | Option exercise | 27,881 | — | Form 4 |
| Jun 12, 2026 | Goldberg Andrew D.Director | Option exercise | 2,954 | — | Form 4 |
| Jun 12, 2026 | YARNO WENDY LDirector | Option exercise | 2,954 | — | Form 4 |
| Jun 12, 2026 | LINK WILLIAM J PHDDirector | Option exercise | 2,954 | — | Form 4 |
| Jun 12, 2026 | Morrison Scott WDirector | Option exercise | 2,954 | — | Form 4 |
| Jun 12, 2026 | Goodrich KatherineDirector | Option exercise | 2,954 | — | Form 4 |
| Jun 12, 2026 | CHAUDHURI BHASKARDirector | Option exercise | 2,954 | — | Form 4 |
| Apr 24, 2026 | PYOTT DAVID E IDirector | Option exercise | 1,383 | — | Form 4 |
| Mar 20, 2026 | Neervannan SeshadriChief Operating Officer | Sale | 2,989 | $199.52K | Form 4 |
| Mar 19, 2026 | Wahl BryanGeneral Counsel | Sale | 4,231 | $283.48K | Form 4 |
| Mar 19, 2026 | Azamian Bobak R.President/CEO and Board Chair | Sale | 11,964 | $801.59K | Form 4 |
| Mar 19, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 390 | $26.13K | Form 4 |
| Mar 19, 2026 | Mottiwala AzizChief Commercial Officer | Sale | 4,440 | $297.48K | Form 4 |
| Mar 19, 2026 | Farrow Jeffrey SSee Remarks | Sale | 2,186 | $146.46K | Form 4 |
| Mar 19, 2026 | Whitfield Dianne C.Chief Human Resources Officer | Sale | 4,174 | $279.66K | Form 4 |
| Mar 19, 2026 | Neervannan SeshadriChief Operating Officer | Sale | 4,589 | $307.46K | Form 4 |
| Mar 18, 2026 | Wahl BryanGeneral Counsel | Sale | 4,125 | $283.43K | Form 4 |
| Mar 18, 2026 | Azamian Bobak R.President/CEO and Board Chair | Sale | 11,667 | $801.64K | Form 4 |
| Mar 18, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 379 | $26.04K | Form 4 |
| Mar 18, 2026 | Mottiwala AzizChief Commercial Officer | Sale | 4,330 | $297.51K | Form 4 |
| Mar 18, 2026 | Farrow Jeffrey SSee Remarks | Sale | 2,133 | $146.56K | Form 4 |
| Mar 18, 2026 | Whitfield Dianne C.Chief Human Resources Officer | Sale | 4,071 | $279.72K | Form 4 |
| Mar 18, 2026 | Neervannan SeshadriChief Operating Officer | Sale | 3,610 | $248.04K | Form 4 |
| Mar 17, 2026 | Wahl BryanGeneral Counsel | Sale | 4,084 | $283.51K | Form 4 |
| Mar 17, 2026 | Azamian Bobak R.President/CEO and Board Chair | Sale | 10,972 | $761.68K | Form 4 |
| Mar 17, 2026 | Lin Elizabeth YeuChief Medical Officer | Sale | 375 | $26.03K | Form 4 |
| Mar 17, 2026 | Mottiwala AzizChief Commercial Officer | Sale | 4,286 | $297.53K | Form 4 |
| Mar 17, 2026 | Farrow Jeffrey SSee Remarks | Sale | 2,111 | $146.55K | Form 4 |
| Mar 17, 2026 | Whitfield Dianne C.Chief Human Resources Officer | Sale | 4,029 | $279.69K | Form 4 |
| Mar 17, 2026 | Neervannan SeshadriChief Operating Officer | Sale | 3,125 | $216.94K | Form 4 |
| Mar 16, 2026 | LINK WILLIAM J PHDDirector | Sale | 493 | $34.39K | Form 4 |
| Mar 16, 2026 | LINK WILLIAM J PHDDirector | Sale | 8,378 | $578.33K | Form 4 |
| Mar 16, 2026 | LINK WILLIAM J PHDDirector | Sale | 3,629 | $247.10K | Form 4 |
| Mar 15, 2026 | Farrow Jeffrey SSee Remarks | Option exercise | 13,042 | — | Form 4 |
| Mar 15, 2026 | Mottiwala AzizChief Commercial Officer | Option exercise | 26,482 | — | Form 4 |
| Mar 15, 2026 | Neervannan SeshadriChief Operating Officer | Option exercise | 26,287 | — | Form 4 |
| Mar 15, 2026 | Wahl BryanGeneral Counsel | Option exercise | 24,236 | — | Form 4 |
| Mar 15, 2026 | Whitfield Dianne C.Chief Human Resources Officer | Option exercise | 23,909 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4